Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.
Abstract
BACKGROUND: Incidence and mortality of breast cancer vary according to demographic factors such as age, race/ethnicity, socioeconomic status (SES), and geographic region. This study assesses the variation of these factors in the use of adjuvant radiation therapy (RT) after breast-conserving surgery (BCS) among 8 regions of California.
METHODS: The authors identified 85,574 cases of first primary female invasive breast cancer with complete data diagnosed between January 1, 2000 and December 31, 2007. Logistic regression was used to determine the association between race/ethnicity, age, SES, and receipt of RT after BCS within each of the regions of California. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed.
RESULTS: Age was a significant predictor of receipt of RT after BCS in all regions. In Los Angeles (LA), lower SES was associated with decreasing odds of RT. Racial disparities were evident only in LA, where black (OR, 0.85; 95% CI, 0.74-0.97) and Hispanic (OR, 0.86; 95% CI, 0.78-0.96) women were about 15% less likely to receive RT than white women.
CONCLUSIONS: Racial disparities in the receipt of RT after BCS exist only in LA, where African American and Hispanic women are less likely to receive this form of adjuvant treatment. Lower SES was also associated with a reduced likelihood of receipt of RT in LA. Women age 70 years and older are less likely to receive RT after BCS in all regions of California.
Copyright © 2011 American Cancer Society.
Research topics
Related publications
View all publications- Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. Parise CA, Caggiano V. J Cancer Epidemiol. 2014;2014:469251. doi: 10.1155/2014/469251. Epub 2014 May 26Breast Journal2014 May 26
- Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial. Jerant A1, Kravitz RL, Sohler N, Fiscella K, Romero RL, Parnes B, Tancredi DJ, Aguilar-Gaxiola S, Slee C, Dvorak S, Turner C, Hudnut A, Prieto F, Franks P.Ann Fam Med. 2014 May-Jun;12(3):204-14. doi: 10.1370/afm.1623. Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial.2014 May 30
- Clin Colorectal Cancer. 2005 Jan;4(5):325-31. 5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study. D'Andre S1, Sargent DJ, Cha SS, Buroker TR, Kugler JW, Goldberg RM, O'Connell MJ, Poon MA.Clin Colorectal Cancer. 20052005 Jan 20
- Schernhammer ES, Thompson CA.Occup Environ Med. 68(5):310-1. doi: 10.1136/oem.2010.058222. Epub 2010 Oct 4.2011 May 01
- Org Biomol Chem. 2013 Jul 28;11(28):4591-601. doi: 10.1039/c3ob40360b. Epub 2013 May 2. Meta-analysis in asymmetric catalysis. Influence of chelate geometry on the roles of PN chelating ligands. Carroll MP1, Guiry PJ, Brown JM. Author information 1School of Chemistry and Chemical Biology, Centre for Synthesis and Chemical Biology, University College Dublin, Dublin 4, Ireland.Org Biomol Chem. 2013 Jul 28;11(28):4591-601. doi: 10.1039/c3ob40360b. Epub 2013 May 2. Meta-analysis in asymmetric catalysis. Influence of chelate geometry on the roles of PN chelating ligands. Carroll MP1Guiry PJBrown JM. Author information 1School of Chemistry and Chemical BiologyCentre for Synthesis and Chemical BiologyUniversity College DublinDublin 4Ireland.2013 Jul 28




